Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Disease Progression × famitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Solid Tumor 1 Small Cell Lung Carcinoma 1 Neoplasms 1 Disease Progression 1 Breast Neoplasms 1

Interventions

fludarabine 1 famitinib 1 encorafenib 1 camrelizumab 1 TPI-287 1 Sodium Selenite 1 Nivolumab 1 Ifosfamide 1 Cyclophosphamide 1 Clinical Trials, Phase II as Topic 1 Clinical Trials, Phase I as Topic 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04044378 2020-05-19

Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma

Peking University People's Hospital

Phase 1/2 Withdrawn

Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡